Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10179816 | Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type II | Isabelle Navarro-Teulon | 2019-01-15 |
| 9879089 | Use of ADCC-optimized antibodies for treating low-responder patients | Dominique Bourel, Sylvie Jorieux, Christophe De Romeuf, Philippe Klein, Nicolas Bihoreau +1 more | 2018-01-30 |
| 9873745 | Antibody method for treatment of a disease in which the target cells are cells which express CD20 | Christophe De Romeuf, Jean-Luc Teillaud, Jean-François PROST | 2018-01-23 |
| 9511138 | Pharmaceutical compositions comprising an antibody which binds the human anti-mullerian hormone receptor type II | Isabelle Navarro-Teulon | 2016-12-06 |
| 9234045 | Monoclonal antibody directed against CD20 antigen | Christophe De Romeuf, Jean-Luc Teillaud, Jean-François PROST | 2016-01-12 |
| 9109020 | Use of ADCC-optimized antibodies for treating weak patients | Dominique Bourel, Sylvie Jorieux, Christophe de Romeuf, Philippe Klein, Nicolas Bihoreau +1 more | 2015-08-18 |
| 8501171 | Use of ADCC-optimized antibodies for treating weak patients | Dominique Bourel, Sylvie Jorieux, Christophe De Romeuf, Philippe Klein, Nicolas Bihoreau +1 more | 2013-08-06 |
| 8404241 | Anti-rhesus D monoclonal antibody | Sylvie Jorieux, Christophe De Romeuf | 2013-03-26 |
| 8038993 | Cytotoxic antibodies directed against antibodies inhibiting factor VIII | Christian Behrens, Christophe De Romeuf | 2011-10-18 |
| 7713524 | Use of ADCC-optimized antibodies for treating low-responder patients | Dominique Bourel, Sylvie Jorieux, Christophe de Romeuf, Philippe Klein, Nicolas Bihoreau +1 more | 2010-05-11 |
| 7595165 | Method of measuring activation of effector cells | Christophe de Romeuf, Arnaud Clacet, Frederic Dhainaut, Dominique Bourel, Nicolas Bihoreau +1 more | 2009-09-29 |